Compound from bear bile helps slow diabetes in mice

A new study from Science Translational Medicine (DOI:10.1126/scitranslmed.3006534) presents data showing that tauroursodeoxycholic acid (TUDCA), a compound isolated from the bile of bears, may actually slow the development of type 1 diabetes (in mice at least). It is thought to work by reducing stress responses from the endoplasmic reticulum in the insulin-producing beta cells of the pancreas which become defective in type 1 diabetes. Use of bear bile is common in traditional Chinese medicine, and at one time led to near-extinction of black bears in China. Fortunately, synthetic versions of the compound are available and have also been shown to be effective in treating ocular diseases (DOI:10.1007/s12177-009-9030-x).

Chinese medicines made from bear bile. Image from Bornean Sun Bear Conservation Centre. Chinese medicines made from bear bile. Image from Bornean Sun Bear Conservation Centre.

More like this

Photo of zebrafish housed at a research institute. By Karol Głąb CC BY-SA 3.0. via Wikimedia Commons Who would have thought tiny fish could lead to big advances in medicine? Zebrafish (Danio rerio) and mammals have similar anatomy and physiology of the brain, eyes, gut, and cardiovascular…
tags: researchblogging.org, osteocalcin, type 2 diabetes, obesity, bones, medicine Even though bones seem to be metabolically inactive structures, nothing could be further from the truth. In fact, bones are rebuilt constantly through the action of cells known as osteoblasts while old bone is…
This entry is cross posted from the the SITN Flash, a bimonthly publication written and edited by Harvard graduate students. You can find my piece, as well as archives of previous articles written by many graduate students at the Science in the News website. In 1985, the Centers for Disease Control…
This new paper from Stem Cells is a wonderful example of the potential of human embryonic stem cells (hESC) to treat diseases like Type I diabetes. The reason type I diabetes is such an obvious target for hESC therapy get a little complicated, but I'll walk you guys through this paper, and recent…